跳至主要内容
临床试验/2024-518692-56-00
2024-518692-56-00招募中4 期

The optimal timing of vaccination in pregnancy: a multi-dimensional mechanistic approach to measure immune responses in pregnant women (MATIMMUNE)

University Of Antwerp1 个研究点 分布在 1 个国家目标入组 96 人开始时间: 2024年10月24日最近更新:
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
96
试验地点
1
主要终点
Measurement of antibody levels and functional antibody characteristics in maternal blood with Tdap vaccination at different timings in pregnancy (measurement at baseline, after Tdap vaccination, at delivery and 6 months postpartum).

研究概览

简要总结

To assess the impact of timing of pertussis vaccination in pregnancy on humoral and cellular immune responses in pregnant women, at delivery and postpartum.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 64 years(18-64 Years)
性别
Female
接受健康志愿者

入选标准

  • Ability to provide informed consent.
  • Willing to be vaccinated with a Tdap vaccine during pregnancy.
  • Intend to be available for follow-up visits and phone call access until 6 months postpartum.
  • Influenza and COVID-19 vaccination during pregnancy (as per Belgian recommendations) is allowed.

排除标准

  • Vaccinated with an aP containing vaccine during the last 5 years.
  • Significant mental illness (e.g. schizophrenia, psychosis, major depression).
  • Serious underlying immunological condition (e.g. immunosuppressive disease or therapy, human immunodeficiency virus (HIV) infection…).
  • Systemic treatment with immune suppressive medication, including chronic steroid use of > 10 mg prednisone or equivalent.
  • Anything in the opinion of the investigator that would prevent volunteers from completing the study or put the volunteer at risk.
  • Previous severe reaction to any vaccine
  • High risk for serious obstetrical complications.

结局指标

主要结局

Measurement of antibody levels and functional antibody characteristics in maternal blood with Tdap vaccination at different timings in pregnancy (measurement at baseline, after Tdap vaccination, at delivery and 6 months postpartum).

Measurement of antibody levels and functional antibody characteristics in maternal blood with Tdap vaccination at different timings in pregnancy (measurement at baseline, after Tdap vaccination, at delivery and 6 months postpartum).

次要结局

  • Measurement of cytokine levels and T-cell subsets in maternal blood after Tdap vaccination at different timings in pregnancy (measurement at baseline, after Tdap vaccination, at delivery and 6 months postpartum).
  • Measurement of antibody levels in cord blood at delivery after Tdap vaccination at different timings in pregnancy to calculate the transport of antibodies across the placenta.
  • Measurement of antibody levels, subclass antibody levels, antibody glycosylation and antibody functionality in breastmilk 6 months postpartum after Tdap vaccination at different timings in pregnancy.

研究者

申办方类型
Educational Institution
责任方
Principal Investigator
主要研究者

Kirsten Maertens

Scientific

University Of Antwerp

研究点 (1)

Loading locations...

相似试验